Page last updated: 2024-08-24

fropenem and Respiratory Tract Infections

fropenem has been researched along with Respiratory Tract Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's7 (77.78)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM1
Abe, T; Azagami, S; Bamba, M; Cho, H; Hojo, H; Jozaki, K; Koizumi, Y; Nakao, A; Nonoyama, M; Ojima, T; Ozaki, A; Sunakawa, K; Yokota, T1
Blosser-Middleton, RS; Critchley, IA; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C1
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y1
Sakata, H1
Amyes, AK; Amyes, SG; Walsh, F1
Akita, H; Goshima, T; Ishihara, T; Iwai, N; Iwata, S; Kanemura, H; Kato, T; Kusumoto, Y; Meguro, H; Nakamura, H; Nakashima, M; Satoh, Y; Sunakawa, K; Terashima, I; Toyonaga, Y; Yokota, T1
Arata, J; Moritono, S; Saito, A1
Capper, TP; du Plessis, M; Klugman, KP1

Trials

1 trial(s) available for fropenem and Respiratory Tract Infections

ArticleYear
[Clinical evaluation of faropenem against infections in pediatric fields].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:9

    Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Diarrhea; Dosage Forms; Drug Therapy, Combination; Female; Humans; Infant; Lactams; Male; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections

1997

Other Studies

8 other study(ies) available for fropenem and Respiratory Tract Infections

ArticleYear
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States

2007
[Efficacy and safety of faropenem in pediatric patients with bacterial infectious diseases].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:6

    Topics: beta-Lactams; Child; Child, Preschool; Dosage Forms; Drug Resistance, Bacterial; Humans; Otitis Media; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Treatment Outcome; Urinary Tract Infections

2008
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Europe; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae

2003
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
    The Japanese journal of antibiotics, 2001, Volume: 54 Suppl B

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors

2001
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    The Japanese journal of antibiotics, 2001, Volume: 54 Suppl B

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome

2001
The in vitro effects of faropenem on lower respiratory tract pathogens isolated in the United Kingdom.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom

2003
[Significant role of penem antibiotics: focused on faropenem (discussion)].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:7

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Lactams; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections

1997
In vitro activity of faropenem against respiratory pathogens.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactams; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae

2002